The latest price target for Staar Surgical (NASDAQ:STAA) was reported by Canaccord Genuity on November 1, 2024. The analyst firm set a price target for $31.00 expecting STAA to rise to within 12 months (a possible 16.41% upside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for Staar Surgical (NASDAQ:STAA) was provided by Canaccord Genuity, and Staar Surgical maintained their hold rating.

The last upgrade for Staar Surgical Co happened on June 11, 2024 when BTIG raised their price target to $46. BTIG previously had a neutral for Staar Surgical Co.

The last downgrade for Staar Surgical Co happened on July 15, 2024 when Morgan Stanley changed their price target from $50 to $37 for Staar Surgical Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Staar Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Staar Surgical was filed on November 1, 2024 so you should expect the next rating to be made available sometime around November 1, 2025.

While ratings are subjective and will change, the latest Staar Surgical (STAA) rating was a maintained with a price target of $41.00 to $31.00. The current price Staar Surgical (STAA) is trading at is $26.63, which is out of the analyst’s predicted range.